Effects of some coronary "vasodilators" on myocardial catecholamine.
D000818:Animals; D002395:Catecholamines / Q000378:metabolism*; D004176:Dipyridamole / Q000494:pharmacology; D004285:Dogs; D004298:Dopamine / Q000378:metabolism; D004837:Epinephrine / Q000378:metabolism; D005029:Ethylenediamines / Q000494:pharmacology; D009203:Myocardial Infarction / Q000503:physiopathology*; D009206:Myocardium / Q000378:metabolism*; D009526:Nialamide / Q000494:pharmacology; D005996:Nitroglycerin / Q000494:pharmacology; D009638:Norepinephrine / Q000378:metabolism; D010624:Phenelzine / Q000494:pharmacology; D011299:Prenylamine / Q000494:pharmacology; D013806:Theophylline / Q000494:pharmacology; D014665:Vasodilator Agents / Q000494:pharmacology*
D002395:Catecholamines; D005029:Ethylenediamines; D014665:Vasodilator Agents; D004176:Dipyridamole; D013806:Theophylline; D005996:Nitroglycerin; D011299:Prenylamine; D010624:Phenelzine; D009526:Nialamide; D004298:Dopamine; D009638:Norepinephrine; D004837:Epinephrine